https://www.selleckchem.com/pr....oducts/brefeldin-a.h
49). Patients with pT3/T4 had a higher risk of death by 3.335 folds compared to pT2 (95% CI [1.321-8.422], p0.05). No difference was noted in the OS and DFS between the groups who underwent RC post-NAC and CRT post-NAC. These findings further support the possibility of bladder preservation after the treatment with NAC for MIBC. The pathologic T stage at diagnosis is an important prognostic factor regardless of treatment modality. No difference was noted in the OS and DFS between the groups who underwent RC post-NAC and CRT post-
Respect!
Kommentar
Delen
